Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2

Journal of Virology

Volumn 88, Issue 21, 2014, Pages 12276-12295

  Khan, Irfan ^a   Katikaneni, Divya S ^a   Han, Qingxia ^a,d   Sanchez Felipe, Lorena ^a   Hanada, Kentaro ^c   Ambrose, Rebecca L ^b   Mackenzie, Jason M ^b   Konan, Kouacou V ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; DOUBLE STRANDED RNA; DOXYCYCLINE; FOUR PHOSPHATE ADAPTOR PROTEIN 2; GLYCOSPHINGOLIPID; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5A; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VIRUS RNA; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; PLEKHA8 PROTEIN, HUMAN; POLYPHOSPHOINOSITIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PHOSPHOLIPID TRANSFER; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA SYNTHESIS; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS REPLICATION; DRUG EFFECTS; HEPACIVIRUS; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; GLYCOSPHINGOLIPIDS; HEPACIVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; PHOSPHATIDYLINOSITOL PHOSPHATES; VIRUS REPLICATION;

EID: 84908004653     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00970-14     Document Type: Article

References (82)

1. Averhoff FM, Glass N, Holtzman D. 2012. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin. Infect. Dis. 55(Suppl 1):S10-S15. http://dx.doi.org/10.1093/cid/cis361.
2. Lavanchy D. 2011. Evolving epidemiology of hepatitis C virus. Clin. Microbiol. Infect. 17:107-115. http://dx.doi.org/10.1111/j.1469-0691.2010.03432.x.
3. Miller RH, Purcell RH. 1990. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc. Natl. Acad. Sci. U. S. A. 87:2057-2061. http://dx.doi.org/10.1073/pnas.87.6.2057.
4. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973. http://dx.doi.org/10.1002/hep.20819.
5. Bartenschlager R, Lohmann V. 2000. Replication of hepatitis C virus. J. Gen. Virol. 81(Part 7):1631-1648. http://vir.sgmjournals.org/content/81/ 7/1631.long.
6. Kuiken C, Simmonds P. 2009. Nomenclature and numbering of the hepatitis C virus. Methods Mol. Biol. 510:33-53. http://dx.doi.org/10.1007/978-1-59745-394-3_4.
7. Hajarizadeh B, Grebely J, Dore GJ. 2013. Epidemiology and natural history of HCV infection. Nat. Rev. Gastroenterol. Hepatol. 10:553-562. http://dx.doi.org/10.1038/nrgastro.2013.107.
8. Bartenschlager R, Sparacio S. 2007. Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture. Virus Res. 127: 195-207. http://dx.doi.org/10.1016/j.virusres.2007.02.022.
9. Blight KJ, Kolykhalov AA, Rice CM. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290:1972-1974. http://dx.doi.org /10.1126/science.290.5498.1972.
10. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-113. http://dx.doi.org/10.1126/science.285.5424.110.
11. Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, Friebe P, Kallis S, Engel U, Bartenschlager R. 2008. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog. 4:e1000035. http://dx.doi.org/10.1371/journal.ppat.1000035.
12. Masaki T, Suzuki R, Murakami K, Aizaki H, Ishii K, Murayama A, Date T, Matsuura Y, Miyamura T, Wakita T, Suzuki T. 2008. Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J. Virol. 82:7964-7976. http: //dx.doi.org/10.1128/JVI.00826-08.
13. Tellinghuisen TL, Foss KL, Treadaway J. 2008. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog. 4:e1000032. http://dx.doi.org/10.1371/journal.ppat.1000032.
14. Ma Y, Yates J, Liang Y, Lemon SM, Yi M. 2008. NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J. Virol. 82:7624-7639. http://dx.doi.org/10.1128/JVI.00724-08.
15. Yi M, Ma Y, Yates J, Lemon SM. 2007. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J. Virol. 81:629-638. http://dx.doi.org/10.1128 /JVI.01890-06.
16. Han Q, Manna D, Belton K, Cole R, Konan KV. 2013. Modulation of hepatitis C virus genome encapsidation by nonstructural protein 4B. J. Virol. 87:7409-7422. http://dx.doi.org/10.1128/JVI.03523-12.
17. Egger D, Wolk B, Gosert R, Bianchi L, Blum HE, Moradpour D, Bienz K. 2002. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 76:5974-5984. http://dx.doi.org/10.1128/JVI.76.12.5974-5984.2002.
18. Konan KV, Giddings TH, Jr, Ikeda M, Li K, Lemon SM, Kirkegaard K. 2003 Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus. J. Virol. 77:7843-7855. http://dx.doi.org/10.1128/JVI.77.14.7843-7855.2003.
19. Aligo J, Jia S, Manna D, Konan KV. 2009. Formation and function of hepatitis C virus replication complexes require residues in the carboxyterminal domain of NS4B protein. Virology 393:68-83. http://dx.doi.org /10.1016/j.virol.2009.07.033.
20. Han Q, Aligo J, Manna D, Belton K, Chintapalli SV, Hong Y, Patterson RL, van Rossum DB, Konan KV. 2011. Conserved GXXXG-and S/T-like motifs in the transmembrane domains of NS4B protein are required for hepatitis C virus replication. J. Virol. 85:6464-6479. http://dx.doi.org/10.1128/JVI.02298-10.
21. Elazar M, Liu P, Rice CM, Glenn JS. 2004. An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication. J. Virol. 78:11393-11400. http://dx.doi.org/10.1128/JVI.78.20.11393-11400.2004.
22. Lundin M, Monne M, Widell A, Von Heijne G, Persson MA. 2003. Topology of the membrane-associated hepatitis C virus protein NS4B. J. Virol. 77:5428-5438. http://dx.doi.org/10.1128/JVI.77.9.5428-5438.2003.
23. Stone M, Jia S, Heo WD, Meyer T, Konan KV. 2007. Participation of rab5, an early endosome protein, in hepatitis C virus RNA replication machinery. J. Virol. 81:4551-4563. http://dx.doi.org/10.1128/JVI.01366-06.
24. Targett-Adams P, Boulant S, McLauchlan J. 2008. Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication. J. Virol. 82:2182-2195. http://dx.doi.org/10.1128/JVI.01565-07.
25. Manna D, Aligo J, Xu C, Park WS, Koc H, Do Heo W, Konan KV. 2010. Endocytic Rab proteins are required for hepatitis C virus replication complex formation. Virology 398:21-37. http://dx.doi.org/10.1016/j.virol.2009.11.034.
26. El-Hage N, Luo G. 2003. Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA. J. Gen. Virol. 84:2761-2769. http://dx.doi.org/10.1099 /vir.0.19305-0.
27. Gosert R, Egger D, Lohmann V, Bartenschlager R, Blum HE, Bienz K, Moradpour D. 2003. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J. Virol. 77:5487-5492. http://dx.doi.org/10.1128/JVI.77.9.5487-5492.2003.
28. Ishido S, Fujita T, Hotta H. 1998. Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus. Biochem. Biophys. Res. Commun. 244:35-40. http://dx.doi.org/10.1006/bbrc.1998.8202.
29. Ali N, Tardif KD, Siddiqui A. 2002. Cell-free replication of the hepatitis C virus subgenomic replicon. J. Virol. 76:12001-12007. http://dx.doi.org /10.1128/JVI.76.23.12001-12007.2002.
30. Alter MJ. 1997. Epidemiology of hepatitis C. Hepatology 26:62S-65S. http://dx.doi.org/10.1002/hep.510260711.
31. Reiss S, Rebhan I, Backes P, Romero-Brey I, Erfle H, Matula P, Kaderali L, Poenisch M, Blankenburg H, Hiet MS, Longerich T, Diehl S, Ramirez F, Balla T, Rohr K, Kaul A, Buhler S, Pepperkok R, Lengauer T, Albrecht M, Eils R, Schirmacher P, Lohmann V, Bartenschlager R. 2011 Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 9:32-45. http://dx.doi.org/10.1016/j.chom.2010.12.002.
32. Berger KL, Cooper JD, Heaton NS, Yoon R, Oakland TE, Jordan TX, Mateu G, Grakoui A, Randall G. 2009. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc. Natl. Acad. Sci. U. S. A. 106:7577-7582. http://dx.doi.org/10.1073 /pnas.0902693106.
33. Hsu NY, Ilnytska O, Belov G, Santiana M, Chen YH, Takvorian PM, Pau C, van der Schaar H, Kaushik-Basu N, Balla T, Cameron CE, Ehrenfeld E, van Kuppeveld FJ, Altan-Bonnet N. 2010. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141:799-811. http://dx.doi.org/10.1016/j.cell.2010.03.050.
34. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, Abid K, Negro F, Dreux M, Cosset FL, Bartenschlager R. 2006 Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. U. S. A. 103:7408-7413. http://dx.doi.org/10.1073/pnas.0504877103.
35. Friebe P, Lohmann V, Krieger N, Bartenschlager R. 2001. Sequences in the 5' nontranslated region of hepatitis C virus required for RNA replica-tion. J. Virol. 75:12047-12057. http://dx.doi.org/10.1128/JVI.75.24.12047-12057.2001.
36. Gottwein JM, Jensen TB, Mathiesen CK, Meuleman P, Serre SB, Lademann JB, Ghanem L, Scheel TK, Leroux-Roels G, Bukh J. 2011. Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A. J. Virol. 85:8913-8928. http://dx.doi.org/10.1128/JVI.00049-11.
37. Godi A, Di Campli A, Konstantakopoulos A, Di Tullio G, Alessi DR, Kular GS, Daniele T, Marra P, Lucocq JM, De Matteis MA. 2004. FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P. Nat. Cell Biol. 6:393-404. http://dx.doi.org/10.1038/ncb1119.
38. Cao X, Coskun U, Rossle M, Buschhorn SB, Grzybek M, Dafforn TR, Lenoir M, Overduin M, Simons K. 2009. Golgi protein FAPP2 tubulates membranes. Proc. Natl. Acad. Sci. U. S. A. 106:21121-21125. http://dx.doi.org/10.1073/pnas.0911789106.
39. Aizaki H, Lee KJ, Sung VM, Ishiko H, Lai MM. 2004. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324:450-461. http://dx.doi.org/10.1016/j.virol.2004.03.034.
40. Hug P, Lin HM, Korte T, Xiao X, Dimitrov DS, Wang JM, Puri A, Blumenthal R. 2000. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. J. Virol. 74:6377-6385. http://dx.doi.org/10.1128/JVI.74.14.6377-6385.2000.
41. Berger KL, Kelly SM, Jordan TX, Tartell MA, Randall G. 2011. Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication. J. Virol. 85:8870-8883. http://dx.doi.org/10.1128/JVI.00059-11.
42. Reiss S, Harak C, Romero-Brey I, Radujkovic D, Klein R, Ruggieri A, Rebhan I, Bartenschlager R, Lohmann V. 2013. The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of hepatitis C virus NS5A. PLoS Pathog. 9:e1003359. http://dx.doi.org/10.1371/journal.ppat.1003359.
43. Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, Xavier RJ, Chung RT. 2009 A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 5:298-307. http://dx.doi.org/10.1016/j.chom.2009.02.001.
44. Tai AW, Salloum S. 2011. The role of the phosphatidylinositol 4-kinase PI4KA in hepatitis C virus-induced host membrane rearrangement. PLoS One 6:e26300. http://dx.doi.org/10.1371/journal.pone.0026300.
45. Hanada K. 2003. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim. Biophys. Acta 1632:16-30. http://dx.doi.org /10.1016/S1388-1981(03)00059-3.
46. Hanada K, Kumagai K, Tomishige N, Yamaji T. 2009. CERT-mediated trafficking of ceramide. Biochim. Biophys. Acta 1791:684-691. http://dx.doi.org/10.1016/j.bbalip.2009.01.006.
47. Hornemann T, Wei Y, von Eckardstein A. 2007. Is the mammalian serine palmitoyltransferase a high-molecular-mass complex? Biochem. J. 405: 157-164. http://dx.doi.org/10.1042/BJ20070025.
48. Yasuda S, Nishijima M, Hanada K. 2003. Localization, topology, and function of the LCB1 subunit of serine palmitoyltransferase in mammalian cells. J. Biol. Chem. 278:4176-4183. http://dx.doi.org/10.1074/jbc.M209602200.
49. Ciesek S, Steinmann E, Manns MP, Wedemeyer H, Pietschmann T. 2008 The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase. J. Infect. Dis. 198:1091-1093. http://dx.doi.org/10.1086/591463.
50. D' Angelo G, Polishchuk E, Di Tullio G, Santoro M, Di Campli A, Godi A, West G, Bielawski J, Chuang CC, van der Spoel AC, Platt FM, Hannun YA, Polishchuk R, Mattjus P, De Matteis MA. 2007. Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide. Nature 449:62-67. http://dx.doi.org/10.1038/nature06097.
51. D' Angelo G, Rega LR, De Matteis MA. 2012. Connecting vesicular transport with lipid synthesis: FAPP2. Biochim. Biophys. Acta 1821:1089-1095 http://dx.doi.org/10.1016/j.bbalip.2012.01.003.
52. Goueslain L, Alsaleh K, Horellou P, Roingeard P, Descamps V, Duverlie G, Ciczora Y, Wychowski C, Dubuisson J, Rouille Y. 2010. Identification of GBF1 as a cellular factor required for hepatitis C virus RNA replication. J. Virol. 84:773-787. http://dx.doi.org/10.1128/JVI.01190-09.
53. Zhang L, Hong Z, Lin W, Shao RX, Goto K, Hsu VW, Chung RT. 2012. ARF1 and GBF1 generate a PI4P-enriched environment supportive of hepatitis C virus replication. PLoS One 7:e32135. http://dx.doi.org/10.1371/journal.pone.0032135.
54. Bieberich E, Freischutz B, Suzuki M, Yu RK. 1999. Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells. J. Neurochem. 72:1040-1049.
55. Platt FM, Neises GR, Reinkensmeier G, Townsend MJ, Perry VH, Proia RL, Winchester B, Dwek RA, Butters TD. 1997. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science 276:428-431. http://dx.doi.org/10.1126/science.276.5311.428.
56. Platt FM, Reinkensmeier G, Dwek RA, Butters TD. 1997. Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycin. J. Biol. Chem. 272:19365-19372. http://dx.doi.org/10.1074/jbc.272.31.19365.
57. Rawat SS, Johnson BT, Puri A. 2005. Sphingolipids: modulators of HIV-1 infection and pathogenesis. Biosci. Rep. 25:329-343. http://dx.doi.org/10.1007/s10540-005-2894-5.
58. Casson L, Howell L, Mathews LA, Ferrer M, Southall N, Guha R, Keller JM, Thomas C, Siskind LJ, Beverly LJ. 2013. Inhibition of ceramide metabolism sensitizes human leukemia cells to inhibition of BCL2-like proteins. PLoS One 8:e54525. http://dx.doi.org/10.1371/journal.pone.0054525.
59. Komori H, Ichikawa S, Hirabayashi Y, Ito M. 1999. Regulation of intracellular ceramide content in B16 melanoma cells. Biological implications of ceramide glycosylation. J. Biol. Chem. 274:8981-8987.
60. Ye J, Wang C, Sumpter R, Jr, Brown MS, Goldstein JL, Gale M, Jr. 2003. Disruption of hepatitisCvirusRNAreplication through inhibition of host protein geranylgeranylation. Proc. Natl. Acad. Sci. U. S. A. 100:15865-15870 http://dx.doi.org/10.1073/pnas.2237238100.
61. D' Angelo G, Uemura T, Chuang CC, Polishchuk E, Santoro M, Ohvo-Rekila H, Sato T, Di Tullio G, Varriale A, D' Auria S, Daniele T, Capuani F, Johannes L, Mattjus P, Monti M, Pucci P, Williams RL, Burke JE, Platt FM, Harada A, De Matteis MA. 2013. Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi. Nature 501:116-120. http://dx.doi.org/10.1038/nature12423.
62. Shi ST, Lee KJ, Aizaki H, Hwang SB, Lai MM. 2003. Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J. Virol. 77:4160-4168. http://dx.doi.org/10.1128/JVI.77.7.4160-4168.2003.
63. Wang H, Perry JW, Lauring AS, Neddermann P, De Francesco R, Tai AW. 2014. Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required forHCVreplication membrane integrity and cholesterol trafficking. Gastroenterology 146:1373-1385. http://dx.doi.org/10.1053/j.gastro.2014.02.002.
64. Manna D, Aligo J, Xu C, Park WS, Koc H, Heo WD, Konan KV. 2010. Endocytic Rab proteins are required for hepatitis C virus replication complex formation. Virology 398:21-37. http://dx.doi.org/10.1016/j.virol.2009.11.034.
65. Wolk B, Buchele B, Moradpour D, Rice CM. 2008. A dynamic view of hepatitis C virus replication complexes. J. Virol. 82:10519-10531. http: //dx.doi.org/10.1128/JVI.00640-08.
66. Santiago-Tirado FH, Bretscher A. 2011. Membrane-trafficking sorting hubs: cooperation between PI4P and small GTPases at the trans-Golgi network. Trends Cell Biol. 21:515-525. http://dx.doi.org/10.1016/j.tcb.2011.05.005.
67. Amako Y, Sarkeshik A, Hotta H, Yates J, III, Siddiqui A. 2009. Role of oxysterol binding protein in hepatitis C virus infection. J. Virol. 83:9237-9246 http://dx.doi.org/10.1128/JVI.00958-09.
68. Bishe B, Syed GH, Field SJ, Siddiqui A. 2012. Role of phosphatidylinositol 4-phosphate (PI4P) and its binding protein GOLPH3 in hepatitis C virus secretion. J. Biol. Chem. 287:27637-27647. http://dx.doi.org/10.1074/jbc.M112.346569.
69. Hanada K, Nishijima M. 2003. Purification of mammalian serine palmitoyltransferase, a hetero-subunit enzyme for sphingolipid biosynthesis, by affinity-peptide chromatography. Methods Mol. Biol. 228:163-174. http: //dx.doi.org/10.1385/1-59259-400-X:163.
70. Hirata Y, Ikeda K, Sudoh M, Tokunaga Y, Suzuki A, Weng L, Ohta M, Tobita Y, Okano K, Ozeki K, Kawasaki K, Tsukuda T, Katsume A, Aoki Y, Umehara T, Sekiguchi S, Toyoda T, Shimotohno K, Soga T, Nishijima M, Taguchi R, Kohara M. 2012. Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis. PLoS Pathog. 8:e1002860. http://dx.doi.org/10.1371/journal.ppat.1002860.
71. Weng L, Hirata Y, Arai M, Kohara M, Wakita T, Watashi K, Shimotohno K, He Y, Zhong J, Toyoda T. 2010. Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner. J. Virol. 84:11761-11770. http://dx.doi.org/10.1128/JVI.00638-10.
72. Kawano M, Kumagai K, Nishijima M, Hanada K. 2006. Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT. J. Biol. Chem. 281:30279-30288. http://dx.doi.org/10.1074/jbc.M605032200.
73. Kumagai K, Yasuda S, Okemoto K, Nishijima M, Kobayashi S, Hanada K. 2005. CERT mediates intermembrane transfer of various molecular species of ceramides. J. Biol. Chem. 280:6488-6495. http://dx.doi.org/10.1074/jbc.M409290200.
74. Hanada K, Kumagai K, Tomishige N, Kawano M. 2007. CERT and intracellular trafficking of ceramide. Biochim. Biophys. Acta 1771:644-653 http://dx.doi.org/10.1016/j.bbalip.2007.01.009.
75. Yamaji T, Kumagai K, Tomishige N, Hanada K. 2008. Two sphingolipid transfer proteins, CERT and FAPP2: their roles in sphingolipid metabolism. IUBMB Life 60:511-518. http://dx.doi.org/10.1002/iub.83.
76. Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M. 2003. Molecular machinery for non-vesicular trafficking of ceramide. Nature 426:803-809. http://dx.doi.org/10.1038/nature02188.
77. Wang H, Perry JW, Lauring AS, Neddermann P, De Francesco R, Tai AW. 2014. Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required forHCVreplication membrane integrity and cholesterol trafficking. Gastroenterology 146:1373-1385. http://dx.doi.org/10.1053/j.gastro.2014.02.002.
78. Su WC, Chao TC, Huang YL, Weng SC, Jeng KS, Lai MM. 2011. Rab5 and class III phosphoinositide 3-kinase Vps34 are involved in hepatitis C virus NS4B-induced autophagy. J. Virol. 85:10561-10571. http://dx.doi.org/10.1128/JVI.00173-11.
79. Paul D, Hoppe S, Saher G, Krijnse-Locker J, Bartenschlager R. 2013. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment. J. Virol. 87:10612-10627. http: //dx.doi.org/10.1128/JVI.01370-13.
80. Kamlekar RK, Simanshu DK, Gao YG, Kenoth R, Pike HM, Prendergast FG, Malinina L, Molotkovsky JG, Venyaminov SY, Patel DJ, Brown RE. 2013 The glycolipid transfer protein (GLTP) domain of phosphoinositol 4-phosphate adaptor protein-2 (FAPP2): structure drives preference for simple neutral glycosphingolipids. Biochim. Biophys. Acta 1831:417-427. http://dx.doi.org/10.1016/j.bbalip.2012.10.010.
81. Tuuf J, Mattjus P. 2014. Membranes and mammalian glycolipid transferring proteins. Chem. Phys. Lipids 178:27-37. http://dx.doi.org/10.1016 /j.chemphyslip.2013.10.013.
82. Lenoir M, Coskun U, Grzybek M, Cao X, Buschhorn SB, James J, Simons K, Overduin M. 2010. Structural basis of wedging the Golgi membrane by FAPP pleckstrin homology domains. EMBO Rep. 11:279-284 http://dx.doi.org/10.1038/embor.2010.28.